Replies to post #53965 on Applied DNA Sciences Inc (APDN)

[Parkmart]

I owned ushg before the Ionatron reverse merger bringing Ionatron public:

“There have been a few discussions in the micro-cap section regarding USHG. Today it closed at $6.00 even after trading as high as $8.00 the previous week.
The reason that this should no longer be discussed in the micro cap section is that after April 29, 2004 AMHG/Ionatron will very soon no longer be a micro cap stock. It will be changing it's name and stock symbol and seek a listing on the Nasdaq or AMEX.”

In the case of this reverse merger it turned out to be better to wait a week after the merger before selling.

In the case of a buyout, board approved, you just wait til buyout is concluded.

In the case of multiple, competing bids, without board approval, I would sell on the news.

[mcsharkey]

Damn Red, envious of your averaging down level, good job.

All buyouts /mergers are negotiated uniquely to the circumstances at hand. Terms and conditions vary wildly. An example of a nice experience is this week's merger between L3 Comm and Harris.
L3 Com stock merged 1-to-1 with higher valued Harris. And Harris had a nice kick for their legacy holders. Not as much gain for them, but a gain.

Hostile buyout examples are ruinous for retail holders.

On a share holder rights kind of buyout, I understand it over-simply and don't see us merging with any multinational. So looking at the possible offering as where our share price may rise to, then merged with.

D
My simplified example using Danaher. They're right around $100 pps.

For our 32 million shares float, my logic puts any Billion $ offer raises us to $30. 2 billion is $60, etc.

$3B gets us closer to a 1 to 1 absorption. Anything lower may cause the buyer to have merge our shares prior to merger (e.g 5:1).

ORRR! Dunno. Any terms they dream up may be plausible.

Mine are overly optimistic.
GLTUA